Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes President & CEO gave up 6,560 shares (to pay taxes)
  2. 4 Grant or award President & CEO acquired 103,400 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 36,700 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Legal Officer gave up 1,735 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief People Officer gave up 1,735 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,255 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Business Officer gave up 1,735 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Exit or restructuring costs · Regulation FD disclosure
  18. SC 13G Stake Amended Statement of Ownership
  19. 4 Grant or award Director acquired 1,687 shares (grant or award)
  20. 4 Grant or award Director acquired 1,725 shares (grant or award)

Page 12 of 28 · 549 filings